Gritstone bio to Participate in Upcoming Investor Conference
EMERYVILLE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop...
Month: January 2024
Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia
Financing was led by New Enterprise Associates (NEA) and closed with additional new investor Atlas Venture and continued investment by...
MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China
LA JOLLA, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
Samsung Bioepis Releases First Quarter 2024 US Biosimilar Market Report
Report highlights latest biosimilar pricing and market share status, including state of the adalimumab marketBiosimilar Deep Dive section illustrates patient...
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation...
Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd
The Combined Company Is Expected To Trade On Nasdaq Post-Closing Under A New Ticker SymbolMediforum is a leading biotechnology company...
Arvinas Appoints Jared Freedberg as General Counsel
Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4)NEW HAVEN, Conn., Jan. 16, 2024 (GLOBE NEWSWIRE)...
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose...
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company...
Psyched Wellness Provides Update on Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - January 17, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review
UTILITY has received a Prescription Drug User Fee Act (PDUFA) target action date of April 24, 2024FDA granted Qualified Infectious...
PrestoDoctor Expands Its Cannabis Telemedicine Service to West Virginia
MESQUITE, NV / ACCESSWIRE / January 17, 2024 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated...
Bioz and Innovative Research Forge a Dynamic Partnership to Advance Research Excellence
PALO ALTO, CA / ACCESSWIRE / January 17, 2024 / Bioz, Inc., a leading Silicon Valley-based AI software company committed...
Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling
GENEVA, SWITZERLAND / ACCESSWIRE / January 17, 2024 / With cancer projected to escalate to 29 million cases by 2040,...
Poolbeg Pharma PLC Announces Further Data Shows POLB001 Potential in Cancer CRS
Further Data Confirms POLB 001's Potential in Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS)Market opportunity estimated to be greater than US$1...
PMD – New Name and Ticker Symbol; Irish Minister to Attend Bell-Ringing Ceremony
STOCKHOLM, SWEDEN / ACCESSWIRE / January 16, 2024 / Promore Pharma (STO:PROMO) (FRA:8T0) Following the reverse acquisition of Promore Pharma...
New Testing Facility for The Osmolality Lab Expands Capacity
The new facility, announced in 2023, tests products for clients across the globe.KANNAPOLIS, NC / ACCESSWIRE / January 16, 2024...
Introducing Elument: Trailblazing the Future of Mental Health and Wellness
NASHVILLE, TN / ACCESSWIRE / January 16, 2024 / Elument,a trailblazer in mental health & wellness services, is proud to...
Prior Authorization Leader Voluware Unveils New Company Brand, Valer®
Rebranding tied to its popular workflow automation solution by the same nameHUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--Voluware formally reintroduces itself today as...
Salucro Announces Expansion of Integrated Patient Payment Workflow Solution for Cerner Millennium® Customers
Current and future Salucro customers using the Cerner Millennium® platform now have access to integrated payment applications launched directly within...